Smither John W
- SEC CIK
- 0001559583
In the past year, 2 open-market sale filings worth $75.4K and no purchases.
Current role at each company
- NAMS NewAmsterdam Pharma Co N.V.Directoras of Sep 9, 2026
- MBX MBX Biosciences, Inc.Chief Financial Officeras of Aug 4, 2026
- GNLX GENELUX CorpDirectoras of Jul 2, 2026
- ARQT Arcutis Biotherapeutics, Inc.Chief Financial Officeras of Feb 15, 2024
- AMTI Applied Molecular Transport Inc.Directoras of Dec 28, 2023
Show 1 more company
- EFTR eFFECTOR Therapeutics, Inc.Directoras of Jun 22, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $75.4K
- 2 filings
- Net
- −$75.4K
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Smither John W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NAMS NewAmsterdam Pharma Co N.V.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 (view filing)4:30 PM ET | Sep 4 | 5 days | Smither John WDirector | SSale | −1.60K | $25.32 | −$40.5K | −15.4%8.76K after |
GNLX GENELUX Corp
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 (view filing) | Sep 13 | 1 day | Smither John WDirector | SSale | −900 | $20.78 | −$18.7K | −11.5%6.92K after | |
| Jun 7, 2024 (view filing) | May 29 | 9 daysLate | Smither John WDirector | PPurchase | +6.25K | – | – | +90.3%13.2K after | |
| Jun 7, 2024 (view filing) | May 29 | 9 daysLate | Smither John WDirector | PPurchase | +6.25K | – | – | –6.25K after | Derivative |
| Jul 2, 2026 (view filing)4:35 PM ET | Jul 1 | 1 day | Smither John WDirector | SSale | −12.0K | $2.91 | −$34.9K | −11.6%91.4K after |